Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study

BACKGROUND: Unfractionated heparin sodium and nafamostat mesylate have long been used as anticoagulants in continuous kidney replacement therapy (CKRT) where citrate is unavailable. This study aimed to determine whether heparin or nafamostat mesylate used during CKRT was associated with a longer fil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameda, Shinya, Fujii, Tomoko, Ikeda, Junpei, Kageyama, Akira, Takagi, Toshishige, Miyayama, Naoki, Asano, Kengo, Endo, Arata, Uezono, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840945/
https://www.ncbi.nlm.nih.gov/pubmed/36642717
http://dx.doi.org/10.1186/s12882-023-03060-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840945/
https://www.ncbi.nlm.nih.gov/pubmed/36642717
http://dx.doi.org/10.1186/s12882-023-03060-1

Ejemplares similares